Bloomberg reported on Monday, citing a filing, that the supplier slashed the contract first announced in February 2023, citing a change in supply quantity.
Meta’s ad-driven revenue growth remains robust, but heavy AI spending, tax-related earnings volatility, and accounting concerns have weighed on investor confidence.
Robotaxi momentum is lifting Tesla stock, as Waymo still leads, China accelerates competition, and analysts see autonomous rides as a significant long-term driver of valuation for growth.
According to a CNBC report, Wells Fargo reaffirmed its ‘overweight’ rating on Oracle, setting a $280 price target that implies a 46% upside from Friday’s close.
Apple’s stock has rebounded but still lags peers, with hopes for a 2026 inflection hinging on iPhone demand, China strength, and deeper AI integration. Bullets:
China’s Tencent Holdings has gained access to Nvidia’s Blackwell chips via a Tokyo-based cloud service provider operated, according to a report from Barron’s.
FDA placed a clinical hold on the proposed proof-of-concept clinical trial for Simufilam in tuberous sclerosis complex -related epilepsy earlier this week.
Mangoceuticals had also recently filed a trademark application for “MULTI-DAT” with the United States Patent and Trademark Office in a bid to expand into the digital asset space
Nvidia lagged megacap peers amid valuation concerns, China headwinds, and AI bubble fears, though pullback improved multiples and Wall Street remains bullish on long-term growth catalysts.
